It's just a little disgusting, why did you get a tumor? Be alert to this tumor, which, if found, may be late

Gastrointestinal mesothelioma, a tumor that sounds a little strange, is, in layman's terms, a potential malignant tumor produced by the upper extrinsic and muscle tissues of the stomach, which can occur in any part of the gastrointestinal tract or in any part of the abdomen, such as the stomach, colorectal, small intestine, esophageal, etc. 30,000 cases, because the initial symptoms are not obvious, such as stomach pain, vomiting blood, blood and other conditions, often has developed to a very serious point, making the surgery risk is very great. 56-year-old Mr. Taizhou Lin (analytic) fell into this predicament, at the suggestion of a friend, Mr. Lin came to Zhejiang University Medical College affiliated with the first hospital, here to receive a series of precision treatment, "I feel very good now", before discharge, he smiled to us.
just a little "disgusting", did not expect to be malignant tumor "I feel very good now!" "In jiang hospital area of the first hospital attached to Zhejiang University Medical College, we met Mr. Lin, who was about to be discharged from the hospital, and he looked younger than his peers with big, big eyebrows.
although he had just finished his surgery, he was in good spirits, sitting and shaking while his wife was sorting things out, laughing with a burst of laughter from time to time.
Mr. Lin is from Taizhou, has been working in a lighting company, he also do a little small business, so many years of hard work, fell ill, good in his wife carefully care, children are more filial, so there is not much trouble.
October 2019, Mr. Lin, who had always had a good appetite, suddenly benited and nauseous from time to time, and his stomach was particularly unwell after dinner.
didn't take himself seriously, but his attentful wife insisted on taking him to the local hospital.
After abdominal B ultra-examination, found that Mr. Lin's spleen and left kidney between a huge lump, the local hospital first suspected stomach cancer, and then after further examination to determine that it may be gastrointestinal mesothelioma, tumor size of about 7cm x 6cm, and liver metastasis, but also violated the spleen, and pancreas adhesion.
The local hospital said the operation is extremely difficult, suggested that Mr. Lin to the higher hospital for further treatment, to a friend, Mr. Lin learned that Zhejiang University Medical College affiliated with the first hospital gastroenterology director Professor Yu Ji-man's team in the treatment of gastrointestinal mesothelioma has a very rich experience, then drove more than 4 hours to Hangzhou.
Sym accurately "fight" the tumor, the implementation of individual treatment program Mr. Lin is an optimistic person, from beginning to end is directly with the doctor, asked his wife can not have a trace of concealment of his illness, but the first time sitting in ji people director of the specialist clinic, he is still a little nervous: "I this disease is not very difficult to cure?" Director YuJi carefully read Mr. Lin's inspection report, patiently explained to him: "For gastrointestinal mesothelioma, surgical excision is the only cure."
But your tumor is relatively large, directly invades the spleen and pancreatic envelope, and has multiple liver metastasis, plus you have a variety of underlying diseases: high blood pressure, diabetes, renal insanity, and obesity lead to limited pulmonary breathing, if direct surgery, trauma is high, the risk is very high.
"Despite the difficulty, the team of gastroenterology specialists at Zhejiang University Hospital has carried out a number of cases of gastrointestinal mesothelioma treatment, and has also pioneered a new treatment strategy around the world - "new complementary targeted treatment", that is, for patients with gastrointestinal mesothelioma who cannot be operated directly, first take a targeted drug, precision "hit" the tumor, so that the tumor "shrinks", thus creating opportunities for surgery.
" treatment principle is the same, but because each patient's situation is different, so the specific treatment plan is based on people' decisions.
Xiaosun, deputy director of gastroenterology, said.
, they first performed a puncture biopsy on Mr. Lin to identify the pathology, and then genetic testing to confirm the drug's therapeutic target, that is, the choice of the most targeted drug.
Lin embarked on the "new auxiliary targeted treatment" road, because the drug has a certain effect on the kidneys, and Mr. Lin kidney insfusion, so he every month to two months, from Taizhou to Zhejiang University Hospital, to receive blood concentration Monitoring, abdominal B ultra-review, etc. , according to the current physical condition, Zhejiang University Hospital gastroenterology expert team for him to fine-tune the dose of targeted drugs, on the one hand to ensure the effectiveness of drug treatment, but also to closely monitor to prevent Mr. Lin's kidney function damage.
this year, Mr. Lin's daily life has not been greatly affected, he still goes to work as usual, just pay attention to the light diet, can not be too tired.
After targeted treatment, Mr. Lin's gastrointestinal mesothelioma narrowed in October this year in another review, Mr. Lin's gastrointestinal mesothelioma has been reduced to about 4cm x 4cm, the metastasis tumor in the liver has also been reduced, Zhejiang University Hospital's team of experts to launch a "total attack" on it.
multidisciplinary joint efforts to "protect" the operation on October 26, Mr. Lin was admitted to the Jiang Hospital District of Zhejiang University Hospital, began to undergo preoperative examinations.
In order to further ensure the safety of surgery, gastroenterology tissue hepatoscopic pancreatic surgery, oncology, cardiovascular ultrasound center, pathology, blood transfusion and other departments carried out a federation consultation, the surgical program was further discussed and adjusted in detail.
At 8 a.m. on November 3, Mr. Lin was pushed into the operating room, and the operation was performed by Dr. Liu Xiaosun, Deputy Director of Gastroenterology, taking into account that Mr. Lin's gastrointestinal mesothelioma had invaded the spleen and pancreatic envelope and had multiple liver metastases. Dr. Zhu Wei, Dr. Dong Yang and Dr. Zhang Wenxuan of hepato-biliary pancreatic surgery, Dr. Yu Bin, co-chief knife, deputy director of the anesthesiology department, Dr. Wen Xiaohong, director of the team of physicians to carry out anesthesia protection, the operating room Ma Weifang deputy director of the nurse team to organize the full assistance.
as predicted before surgery, the tumor originated at the bottom of the stomach, the tumor tissue invaded the spleen and melted into the spleen, and the surface of the pancreas was also affected by the tumor.
designed by the preoperative surgical team, the patient's spleen and pancreas are freed out of the abdominal cavity to ensure the precise and complete removal of the tumor and the infringing site.
surgery specialists then needed to further remove the in-liver metastasis tumor, which was so thick and so small that it could not be determined directly by touch.
, deputy director of the Cardiovascular Ultrasound Center, was already on the side, and under the precise positioning of B Super, the surgical experts found the liver metastasis stove and removed it.
To join the targeted treatment program before gastrointestinal mesothelioma surgery is a valuable experience gained by the team of gastroenterologists of Zhejiang University hospital in many years of clinical practice and academic research, they began to explore new complementary targeted treatment in 2004, and in 2006 summarized their experience, published academic papers, the first in the world to report on this new treatment strategy.
Yuji said that the main reason for the targeted treatment of patients before surgery is that the tumor can be reduced, so that patients who were previously unable to operate because the tumor is too large to have the opportunity to surgically remove the lesions, but also improve the safety of the operation;
"We can visually liken peri-surgical targeted treatment options to 'sandwiches', i.e. targeted therapy-surgery-targeted therapy."
targeted treatment after surgery can consolidate the effect of surgery, reduce the possibility of tumor recurrence and metastasis, and prolong the survival time of patients.
, " said yuji.
, Mr. Lin has been discharged from the hospital and will continue to undergo targeted treatment after surgery.
Xiaofei Man Source: Zhejiang University Copyright Notice: All text, images and audio and video materials that indicate "Source: Mets Medicine" or "Source: MedSci Originals" are owned by Mets Medical, and are not authorized to be reproduced by any media, website or individual, and shall be reproduced with the words "Source: Mets Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
at the same time reproduced content does not represent the position of this site.
leave a message here